UAMY

United States Antimony Corporation
NYSEUSDEQUITY Basic Materials DELAYED
Last price
3.99
▲ 0.04 (1.01%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
3.95
Day high
4.12
Day low
3.95
Volume
3.58M
Market cap
$597.18M
P/E (TTM)
—
52W range
3.85 – 19.71

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.55% -6.5%
1M
-23.27% -24.4%
3M
-40.27% -44.8%
6M
-50.92% -69.1%
YTD
-20.52% -34.8%
1Y
-48.52% -64.9%
3Y
+978.38% +896.1%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on UAMY open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
12.78M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Sep 1, 26
CARRABBA JOSEPH A
Director
BUY 21.30K $100.54K Direct
Sep 1, 26
BARDSWICH LLOYD JOSEPH
Officer and Director
BUY 20.00K $92.70K Direct
Aug 31, 26
AGUIRRE BLAISE A. M.D.
Director
BUY 1.40K $7.05K Direct
Aug 28, 26
EVANS GARY C
Officer and Director
BUY 20.00K $98.40K Direct
Jun 15, 26
MARINELLI JON R.
Director
BUY 12.50K $93.13K Direct
Jan 15, 26
MCMANUS MICHAEL A JR
Director
STOCK 6.63K $0 Direct
Jan 15, 26
CARRABBA JOSEPH A
Director
STOCK 6.63K $0 Direct
Jan 15, 26
AGUIRRE BLAISE A. M.D.
Director
STOCK 6.63K $0 Direct
Sep 26, 25
EVANS GARY C
Chief Executive Officer
BUY 100.00K $613.20K Direct
May 27, 25
MCMANUS MICHAEL A JR
Director
STOCK 22.73K $0 Direct
May 27, 25
CARRABBA JOSEPH A
Director
STOCK 22.73K $0 Direct
May 27, 25
AGUIRRE BLAISE A. M.D.
Director
STOCK 22.73K $0 Direct
Dec 10, 24
MCMANUS MICHAEL A JR
Director
BUY 70.00K $102.06K Direct
Dec 10, 24
EVANS GARY C
Chief Executive Officer
BUY 200.00K $289.40K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

6 reporting
NameRelationShares heldLatest
AGUIRRE BLAISE A. M.D.
Director 878.09K Purchase
BARDSWICH LLOYD JOSEPH
Officer and Director 932.88K Purchase
CARRABBA JOSEPH A
Director 198.40K Purchase
EVANS GARY C
Officer and Director 2.59M Purchase
MARINELLI JON R.
Director 12.50K Purchase
MCMANUS MICHAEL A JR
Director 538.60K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap$597.18M
Enterprise value$551.45M
Revenue (TTM)$36.44M
Gross profit$6.36M
EBITDA$-22.12M
Net income$-16.26M
EPS (TTM)$-0.13
Free cash flow$-63.09M
Total cash$46.10M
Total debt$364.08K
Book value / share$0.92
Shares outstanding149.67M
Float131.97M
Short % of float23.26%
Dividend yield0.00%
Beta (5Y)0.38

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E38.00
PEG ratio—
Price / sales—
Price / book4.33
EV / revenue15.13
EV / EBITDA-24.93
Gross margin17.44%
Operating margin-88.08%
Profit margin-44.60%
Return on equity-14.87%
Return on assets-12.47%
Debt / equity0.20
Current ratio11.54
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $39.26M$14.94M$8.69M$11.04M +162.8%
Operating revenue $39.26M$14.94M$8.69M$11.04M +162.8%
Cost of revenue $29.38M$11.47M$12.04M$9.05M +156.2%
Gross profit $9.87M$3.47M-$3.34M$2.00M +184.8%
Selling, general & admin $17.06M$5.37M$2.92M$1.44M +217.6%
Total operating expense $18.75M$5.85M$3.51M$1.65M +220.7%
Operating income -$8.88M-$2.38M-$6.85M$348.20K -273.0%
Net interest income $810.55K$668.54K$618.76K$103.80K +21.2%
Pre-tax income -$4.34M-$1.73M-$6.35M$444.73K -150.8%
Tax provision $0$0$0$16.07K —
Net income -$4.34M-$1.73M-$6.35M$428.66K -150.8%
Net income to common -$4.35M-$1.74M-$6.36M$381.38K -150.1%
Basic EPS -0.04-0.02-0.060.00 -100.0%
Diluted EPS -0.04-0.02-0.060.00 -100.0%
EBIT -$8.88M-$2.38M-$6.85M$348.20K -273.0%
EBITDA -$7.71M-$1.29M-$5.89M$1.26M -495.9%
Basic shares 123.64M108.59M107.55M106.29M +13.9%
Diluted shares 123.64M108.59M107.55M106.29M +13.9%

Options analytics

Account required
Put / call volume
0.42
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
1.00
-74.9% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
170
Contracts, this expiry
Put volume
71
Contracts, this expiry
Heaviest call OI
1.00
0 contracts
Heaviest put OI
2.00
0 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.020.00 +100.0%
Mar 2026 -0.02-0.08 -300.0%
Dec 2025 0.00-0.01 0.0%
Sep 2025 0.02-0.04 -366.7%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.02 2 $16.72M +92.1%
Next quarter 0.01 2 $33.98M +160.7%
Current year -0.07 3 $64.95M +65.4%
Next year 0.11 2 $201.83M +210.8%

Analyst targets & ownership

Account required
Mean target$10.44
High target$13.50
Low target$9.00
Implied upside161.59%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders8.54%
Held by institutions63.49%
Institutions holding307
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
4.23
-5.76% from price
SMA 20
4.52
-11.68% from price
SMA 50
5.09
-21.56% from price
SMA 100
6.21
-35.76% from price
SMA 200
7.54
-47.07% from price
EMA 12
4.27
-6.56% from price
EMA 26
4.60
-13.23% from price
EMA 50
5.11
-21.86% from price
RSI (14)
32.7
Neutral
MACD (12,26,9)
-0.33
Hist -0.03
ATR (14)
0.21
5.23% of price
Realised vol 30D
59.2%
Annualised
Bollinger upper
5.24
20, 2σ
Bollinger lower
3.80
20, 2σ
50 / 200 cross
Death
5.09 vs 7.54
Trend bias
Below 200
-47.07%

Options chain

Account required
Expiry
Spot 3.99
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
3.23
More volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
59.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-77.4%
Peak to trough
Max drawdown 5Y
-77.4%
Peak to trough
ATR 14
0.21
5.23% of price
Beta (reported)
0.38
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
33.50M
Prior 33.39M
Change vs prior
+0.3%
Shorts adding
% of float
23.26%
Heavily shorted
% of shares out
22.39%
Against total outstanding
Days to cover
5.2
Crowded exit
Float
131.97M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

18 on file
DateFirm ActionFromTo
Aug 12, 26 HC Wainwright & Co. MAINTAINED Buy Buy
May 18, 26 HC Wainwright & Co. MAINTAINED Buy Buy
Mar 23, 26 HC Wainwright & Co. MAINTAINED Buy Buy
Feb 24, 26 B. Riley Securities MAINTAINED Buy Buy
Feb 3, 26 HC Wainwright & Co. MAINTAINED Buy Buy
Nov 13, 25 HC Wainwright & Co. MAINTAINED Buy Buy
Oct 20, 25 William Blair INITIATED — Outperform
Sep 26, 25 HC Wainwright & Co. MAINTAINED Buy Buy
Aug 14, 25 D. Boral Capital MAINTAINED Buy Buy
Aug 13, 25 HC Wainwright & Co. MAINTAINED Buy Buy
May 12, 25 D. Boral Capital MAINTAINED Buy Buy
May 9, 25 HC Wainwright & Co. MAINTAINED Buy Buy

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.